In the past session, Herborium Group Inc (OTCPink: HBRM) was trading in a range of $0.0021 to $0.0028 with its share price rising up 13.64 percent to conclude the trading of $0.0025. The HBRM stock surged during the Tuesday session after news of its growing product portfolio broke.
How HBRM is expanding its product line?
Herborium is a botanical therapeutics company that develops, licenses, and markets proprietary medicinal botanical products to both consumers and healthcare providers, with the intent of improving lives worldwide. In order to fill a gap between high-risk, high-cost ethical pharmaceuticals and commoditized supplements, the business model of HBRM brings new options to consumers.
It was revealed yesterday that Herborium is making considerable progress toward introducing a novel, all-natural product to the market in the third quarter of this year.
A unique content product will also be launched by 2022, as part of HBRM’s advanced planning stage. Digital commerce depends increasingly on content as a value creator. By 2025, content is expected to generate $414.2 billion in global revenues, increasing from a figure of $208.3 billion of revenue generated in 2019.
Last month, shares of HBRM stock dropped approximately -26.47%; on average, more than 186.45 million shares were traded. Herborium stock gained more than 127.27% in a three-month period, while average volume totaled 425.22M for HBRM stock. Over the year, the HBRM stock price increased more than 2300.00%, hitting a high of $0.0074 with its current market capitalization standing at $16.19M.
How the content will play its role?
A new Artificial Intelligence platform and new content by Herborium (HBRM) will serve as a powerful promotional tool for its existing as well as future products. Through the platform, HBRM will receive a significant revenue boost; contribute to the achievement of business and social media objectives; and be recognized for its significant content platform, said HBRM’s CEO Dr. Agnes Olszewski.